Cubist Systematic Strategies’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Cubist Systematic Strategies’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,184	Closed	-$202K	–	2609
2019 Q4	$202K	Buy	+12,184	New	+$198K	﹤0.01%	2031
2019 Q3	–	Sell	-23,702	Closed	-$326K	–	2613
2019 Q2	$326K	Buy	23,702 +8,232	+53%	+$126K	0.01%	1744
2019 Q1	$267K	Buy	+15,470	New	+$245K	0.01%	1590

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Cubist Systematic Strategies's OXFD Position: Q1 2020 in Review

Cubist Systematic Strategies sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2020, closing a stake of 12,184 shares — an estimated $202K sold.

Cubist Systematic Strategies first reported a position in OXFD in Q1 2019 and held it in 3 quarters. The position peaked at $326K in Q2 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q1 2020.

Cubist Systematic Strategies reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Cubist Systematic Strategies sold 12,184 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2020, an estimated $202K.
Cubist Systematic Strategies first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and held it in 3 quarters.
Cubist Systematic Strategies's Oxford Immunotec Global PLC Ordinary Shares position peaked at $326K in Q2 2019.
65 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2020.

Based on Cubist Systematic Strategies's 13F filing for Q1 2020, filed 15 May 2020.